Russia's Moscow region to announce $50-million tender for supplies of vital drugs

The authorities of Russia’s Moscow region plan to organize a tender for the supplies of certain vital drugs for the needs of local customers, according to the press-service of the government of the Moscow region.

The amount of the potential contract is estimated at almost $50 million, while under its conditions the potential investor should localize production within the Moscow region with the minimum investments of about 1 billion roubles ($15.5 million), reports The Pharma Letter’s local correspondent.

All construction works must be completed within two years after signing of the contract.